Mergers and acquisitions lawyers - corporate law
A multidisciplinary team for strategic and legal assistance in your development projects.
Our experts in mergers, acquisitions and corporate law assist you in your strategic operations and are supported by all the firm’s legal teams dedicated to employment law, tax law, competition law and information technology. Our structured, multidisciplinary, business-oriented team provides an excellent strategic and comprehensive understanding of each case.
DELCADE’s lawyers act in both French and English, and some are qualified to practice in the United Kingdom and the United States. They act on behalf of both French and overseas companies.
For more information
For more information
For more information
For more information
For more information
For more information
For more information
For more information
For more information
Our strengths
Latest news on corporate law
DELCADE welcomes three new talents in M&A, construction & insurance litigation and corporate & restructuring
DELCADE is strengthening its teams with the arrival of three new members: Pauline Dupuy, counsel in corporate law and mergers & acquisitions, Diane Nyessi, associate in construction and insurance litigation, and Charlie Barbier, associate in corporate, litigation & restructuring. These recruitments reflect DELCADE’s commitment to a long-term talent development policy: identifying high-potential profiles, supporting them […]
Read more
Shadow Payroll and International Assignments in France: a compliance guide for foreign employers
Foreign companies deploying employees or executives to France face a layered set of obligations that span employment law, payroll reporting, taxation, social security coordination, and immigration procedures. Managing these requirements in isolation, through separate providers across different jurisdictions, often leads to gaps, duplications, or costly errors. DELCADE’s International Assignment Services practice offers a single integrated […]
Read more
DELCADE advises Geistlich Pharma AG on taking control of OST Développement
The European regenerative medicine market continues to consolidate. On 24 April 2026, the Swiss group Geistlich Pharma AG completed the acquisition of a majority stake in OST Développement, a French specialist in bone regeneration. DELCADE acted as legal counsel to the acquirer, extending a collaboration that began back in 2024. A two-stage M&A move The […]
Read more
